Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer

Breast Cancer Research and Treatment

Volumn 95, Issue 2, 2006, Pages 141-145

  Lener, Marcin Radosław ^a,e   Oszutowska, Dorota ^a   Castaneda, Jennifer ^a   Kurzawski, Grzegorz ^a   Suchy, Janina ^a   Nej Wołosiak, Katarzyna ^a,e   Byrski, Tomasz ^a   Huzarski, Tomasz ^a   Gronwald, Jacek ^a   Szymańska, Anna ^a   Szymańska Pasternak, Jolanta ^a   Grodzki, Tomasz ^b   Serwatowski, Piotr ^c   Brȩborowicz, Grzegorz ^c   Scott, Rodney J ^d   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Regional Hospital for Lung Diseases   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

Breast and lung cancer; NOD2 3020insC

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENE FREQUENCY; GENE INSERTION; GENETIC RISK; HEREDITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT;

AGE OF ONSET; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PREVALENCE;

EID: 33645217871     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9057-z     Document Type: Article

References (23)

1. Brownson RC, Alavanja MC: Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control 11: 853-858, 2000
2. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL: Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 15: 819-827, 2004
3. Knowles H, Leek R, Harris AL: Macrophage infiltration and angiogenesis in human malignancyNovartis Found Symp 256: 189 -200; discussion 200-204, 259-269, 2004
4. Denkert C, Winzer KJ, Hauptmann S: Prognostic impact of cyclooxygenase-2 in breast cancer. Clin Breast Cancer 4: 428-433, 2004
5. Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, Jakubowska A, Debniak T, Cybulski C, Kowalska E, Szych Z, Domagala W, Scott RJ, Lubiński J: The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 64: 1604-1606, 2004
6. Papaconstantinou I, Theodoropoulos G, Gazouli M, Panoussopoulos D, Mantzaris GJ, Felekouras E, Bramis J: Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 114: 433-435, 2005
7. Huzarski T, Lener M, Domagala W, Gronwald J, Byrski T, Kurzawski G, Suchy J, Chosia M, Woyton J, Ucinski M, Narod SA, Lubinski J: The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 89: 91-93, 2005
8. Lubiński J, Huzarski T, Kurzawski G, Suchy J, Masojć B, Mierzejewski M, Lener M, Domagała W, Chosia M, Teodorczyk U, Medrek K, Dȩbniak T, Złowocka E, Gronwald J, Byrski T, Grabowska E, Nej K, Szymańska A, Szymańska J, Matyjasik J, Cybulski C, Jakubowska A, Górski B, Narod SA: The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract 3: 59-63, 2005
9. Bonen DK, Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536, 2003
10. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP: Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99: 2393-2404, 2004
11. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G: Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276: 4812-4818, 2001a
12. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G: Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 276: 2551-2554, 2001
13. Schreiber S, Nikolaus S, Hampe J: Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484, 1998
14. Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA: Activation of nuclear factor kappa B in Crohn's disease. Inflamm Res 47: 440-445, 1998
15. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998
16. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606, 2001b
17. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M: Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307: 734-738, 2005
18. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1998
19. Alhopuro P, Ahvenainen T, Mecklin JP, Juliola M, Jarvinen HJ, Karhu A, Aaltonen LA: NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 64: 7245-7247, 2004
20. Dȩbniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Dȩbniak B, Rozmiarek A, Dziuba I, Zlowocka E, Suchy J, Górski B, Cybulski C, Mierzejewski M, Masojć B, Mȩdrek K, Oszurek O, Lubiński J: NOD2 variants and the risk of malignant melanoma. Eur J Cancer Prev 14: 143-146, 2005
21. Munkholm P: Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2: 1-5, 2003
22. Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F: Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 65: 37-45, 2003
23. Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS, Fain P, Schwartz AG, You M, Franklin W, Klein C, Gazdar A, Rothschild H, Mandal D, Coons T, Slusser J, Lee J, Gaba C, Kupert E, Perez A, Zhou X, Zeng D, Liu Q, Zhang Q, Seminara D, Minna J, Anderson MW: A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 75: 460-474, 2004